Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Positron-Emission Tomography”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT02149173
What this trial is testing

F-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted Therapy

Who this might be right for
Estrogen Receptor PositiveRecurrent Breast CarcinomaStage IV Breast Cancer AJCC v6 and v7
University of Washington 29
Very early researchLooking for participantsNCT06419361
What this trial is testing

[68Ga]Ga-Sa-DABI-4 PET Imaging of Stimulator of Interferon Gene Expression in Cancer Patients

Who this might be right for
Stimulator of Interferon GeneCancerPositron Emission Tomography
First Affiliated Hospital of Chongqing Medical University 30
Not applicableLooking for participantsNCT06421142
What this trial is testing

FAPI and FDG PET/MRI in Diagnosis and Therapy Prediction of Bladder Cancer

Who this might be right for
Urinary Bladder Neoplasms
First Affiliated Hospital of Fujian Medical University 80
Testing effectiveness (Phase 2)Study completedNCT00924313
What this trial is testing

Positron Emission Tomography and Magnetic Resonance Imaging for Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)UnknownNCT00795613
What this trial is testing

Positron Emission Tomography (PET)-Adapted Chemotherapy In Advanced Hodgkin Lymphoma (HL)

Who this might be right for
HODGKIN LYMPHOMA
Ospedale Santa Croce-Carle Cuneo 450
Large-scale testing (Phase 3)Study completedNCT05184088
What this trial is testing

Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL Amyloidosis

Who this might be right for
Cardiac AmyloidosisAL AmyloidosisATTR Amyloidosis
Lantheus Germany GmbH 244
Not applicableStudy completedNCT01338090
What this trial is testing

89Zr-bevacizumab PET Imaging in Patients With Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors
University Medical Center Groningen 14
Not applicableActive Not RecruitingNCT06557148
What this trial is testing

A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer

Who this might be right for
Breast CancerLobular Breast CarcinomaBreast Carcinoma+3 more
Memorial Sloan Kettering Cancer Center 7
Testing effectiveness (Phase 2)Study completedNCT04823065
What this trial is testing

4FMFES-PET Imaging of Endometrial and Ovarian Cancers

Who this might be right for
Endometrial CancerOvarian Cancer
Centre de recherche du Centre hospitalier universitaire de Sherbrooke 53
Large-scale testing (Phase 3)Study completedNCT00606632
What this trial is testing

Pre-surgical Detection of Clear Cell Renal Cell Carcinoma (ccRCC) Using Radiolabeled G250-Antibody

Who this might be right for
Renal Cell CarcinomaKidney Cancer
Heidelberg Pharma AG 226
Early research (Phase 1)WithdrawnNCT04605614
What this trial is testing

64Cu-DOTA-pembrolizumab PET for the Study of PD1 Expression

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
City of Hope Medical Center
Early research (Phase 1)Looking for participantsNCT05892393
What this trial is testing

Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma

Who this might be right for
Multiple MyelomaPlasma Cell Myeloma
Robert Flavell, MD, PhD 20
Not applicableLooking for participantsNCT04983095
What this trial is testing

Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer

Who this might be right for
Prostate Cancer MetastaticRadiation TherapyPositron-Emission Tomography
Karin Soderkvist 118
Not applicableLooking for participantsNCT06916637
What this trial is testing

Clinical Study on the Application of 18F-HER2 Affibody PET Imaging in HER2-Expressing Breast Cancer

Who this might be right for
Breast CancerBreast Cancer, HER2-Expression
The Affiliated Hospital of Qingdao University 40
Not applicableTemporarily Not AvailableNCT06980519
What this trial is testing

MNPR-101-PCTA-177Lu Expanded Access Program (EAP) for Patients With Solid Tumor Cancer

Who this might be right for
CancerSolid TumorSolid Tumor Cancer+3 more
Monopar Therapeutics
Large-scale testing (Phase 3)Study completedNCT06240741
What this trial is testing

A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in Japan

Who this might be right for
Neuroendocrine Neoplasms
Novartis Pharmaceuticals 71
Testing effectiveness (Phase 2)Study completedNCT05160051
What this trial is testing

68Ga-FAPI-46 PET for Imaging of FAP Expressing Cancer

Who this might be right for
Tumor, Solid
University Hospital, Essen 158
Testing effectiveness (Phase 2)Study completedNCT00671437
What this trial is testing

Determine Tumor Response Using Fluorodeoxyglucose (FDG)- Positron Emission Tomography (PET)/Computed Tomography (CT) Before and After Cetuximab in Patients With Head and Neck Cancer

Who this might be right for
Carcinoma, Squamous Cell
Washington University School of Medicine 42
Not applicableUnknownNCT00297557
What this trial is testing

Dual Time Point PET Imaging in Lymphoma

Who this might be right for
Hodgkin's or Non-Hodgkin's Lymphoma
Royal Marsden NHS Foundation Trust
Not applicableLooking for participantsNCT06754345
What this trial is testing

68Ga-NK224 PET Imaging of PD-L1 Expression in Cancers

Who this might be right for
TumorPD-L1
The First Affiliated Hospital of Xiamen University 100
Next Page